Adhera Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Wake Forest, NC
SEC filing record 1 source field available
Fiscal year end
31 December
Adhera Therapeutics, Inc. has filed 1,210 SEC EDGAR filings since 16 Oct 1995

SEC filing history

Showing 151-175 of 575 matching filings.

Per page
25
Current page
7
4

4 filing

Filing date
18 Apr 2018
Reporting date
16 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Apr 2018
Reporting date
16 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Apr 2018
Reporting date
16 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-13789

10-K filing

Filing date
17 Apr 2018
Reporting date
31 Dec 2017
Next action
Verify source filing
NT 10-K File 000-13789

NT 10-K filing

Filing date
03 Apr 2018
Reporting date
31 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 000-13789

CT ORDER filing

Filing date
05 Mar 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q/A File 000-13789

10-Q/A filing

Filing date
09 Feb 2018
Reporting date
30 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-13789

8-K filing

Filing date
16 Jan 2018
Reporting date
11 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-222416

S-8 filing

Filing date
04 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Jan 2018
Reporting date
03 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Jan 2018
Reporting date
03 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Jan 2018
Reporting date
03 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Jan 2018
Reporting date
03 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Jan 2018
Reporting date
03 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-13789

8-K filing

Filing date
29 Dec 2017
Reporting date
22 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-299533

D filing

Filing date
28 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Nov 2017
Reporting date
22 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
27 Nov 2017
Reporting date
22 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-13789

8-K filing

Filing date
24 Nov 2017
Reporting date
22 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
RW File 333-218982

RW filing

Filing date
22 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-13789

10-Q filing

Filing date
13 Nov 2017
Reporting date
30 Sep 2017
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 Oct 2017
Reporting date
12 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
24 Oct 2017
Reporting date
12 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-13789

8-K filing

Filing date
18 Oct 2017
Reporting date
12 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-13789

8-K filing

Filing date
06 Oct 2017
Reporting date
02 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .